![Paolo Tarantino: Nearly 1000 downloads in less than a week for our ATEMPT 5-year publication](https://oncodaily.com/pub/uploads/2024/06/N7-QBrt1_400x400-1-e1719762232283.png)
Paolo Tarantino: Nearly 1000 downloads in less than a week for our ATEMPT 5-year publication
Paolo Tarantino, posted on X:
“Nearly 1000 downloads in less than a week for our ATEMPT 5-year publication.
Thanks to the Journal of Clinical Oncology for including it in the Featured Content! ”
Read more.
Source: Paolo Tarantino/X
Dr. Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan. His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer. With a publication record exceeding 50 papers on breast cancer, he is recognized as a leading expert in the field.